SCHEMBL7009434

SCHEMBL7009434

COc1cc(/C=C2/SC(=O)NC2=O)ccc1OCc1nc2ccccc2c(=O)n1C

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
CISD1 Q9NZ45 2/20 0.58
IGF1R P08069 1/20 0.57
MGAM O43451 1/20 0.57
GAA P10253 1/20 0.57
SI P14410 1/20 0.57
MGAM2 Q2M2H8 1/20 0.57
PIM1 P11309 1/20 0.55
PDE4B Q07343 1/20 0.55
PIM3 Q86V86 1/20 0.55
PIM2 Q9P1W9 1/20 0.55
HPGD P15428 6/20 0.52
PTPN1 P18031 2/20 0.52
CYP3A4 P08684 1/20 0.51
ESRRA P11474 1/20 0.51
ADAMTS5 Q9UNA0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6355409 1.00 MEN1 (0.68) MEN1KMT2ACISD1IGF1RMGAM
SCHEMBL7013434 0.86 HPGD (0.62) PIM1PIM2HPGDPTPN1
SCHEMBL5935568 0.86 HPGD (0.62) PIM1PIM2HPGDPTPN1
SCHEMBL6357262 0.85 HPGD (0.61) PIM1PIM2HPGDPTPN1
SCHEMBL6357256 0.85 HPGD (0.61) PIM1PIM2HPGDPTPN1
SCHEMBL5935564 0.84 KMT2A (0.47) MEN1KMT2ACISD1HPGDPTPN1
SCHEMBL5935567 0.83 KMT2A (0.46) MEN1KMT2ACISD1GAAHPGD
SCHEMBL5935621 0.83 KDM4E (0.54) MEN1KMT2A
SCHEMBL5508722 0.82 MEN1 (1.00) MEN1KMT2ACISD1IGF1RMGAM
SCHEMBL5508719 0.82 MEN1 (1.00) MEN1KMT2ACISD1IGF1RMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958296-B1 HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED DISEASES REDDYS LAB LTD DR (IN) 2003-07-30 EP claimed